GlaxoSmithKline PLC (NYSE:GSK)

39.87
Delayed Data
As of 4:02pm ET
 +0.32 / +0.81%
Today’s Change
34.52
Today|||52-Week Range
42.36
+12.40%
Year-to-Date
Top Research Reports for Wells Fargo, Schlumberger & Biogen
10:51am / Zacks.com - Paid Partner Content
Is Artificial Intelligence the Next Big Thing in Biotech?
Sep 17 / Zacks.com - Paid Partner Content
AstraZeneca's Fasenra Long-Term Asthma Study Data Positive
Sep 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus
Sep 14 / Zacks.com - Paid Partner Content
Should Value Investors Consider Glaxo (GSK) Stock Now?
Sep 19 / Zacks.com - Paid Partner Content
What's Next for Gilead Sciences After Its Latest Clinical Success
Sep 13 / MotleyFool.com - Paid Partner Content
Theravance, Mylan Report Positive Data on COPD Drug Yupelri
Sep 18 / Zacks.com - Paid Partner Content
Merck Gets Priority Review for Yet Another Keytruda sBLA
Sep 13 / Zacks.com - Paid Partner Content
Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV
Sep 17 / Zacks.com - Paid Partner Content
Gilead's Rheumatoid Arthritis Drug Successful in Phase III
Sep 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close39.55
Today’s open39.61
Day’s range39.47 - 39.94
Volume1,985,132
Average volume (3 months)2,330,238
Market cap$98.1B
Data as of 4:02pm ET, 09/20/2018

Growth & Valuation

Earnings growth (last year)+59.84%
Earnings growth (this year)-3.99%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+3.58%
P/E ratio45.0
Price/Sales2.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.95+1.56%
AZNAstraZeneca+0.42+1.13%
NVONovo Nordisk+0.50+1.06%
SNYSanofi+0.25+0.57%
Data as of 4:02pm ET, 09/20/2018

Financials

Next reporting dateOctober 31, 2018
EPS forecast (this quarter)$0.85
Annual revenue (last year)$38.9B
Annual profit (last year)$2.0B
Net profit margin5.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Paul Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts